Suzhou Qilin Pharm-Chemicals Research Co., Ltd. is invested by Jiangxi Qilin Chemical industry Co., Ltd., one of the new high tech enterprises and key enterprises in Jiangxi province. The registered capital for our company is ￥10,000,000, and its scope of business mainly covers chemical raw material, medicine intermediates, and pharmaceutical raw material techniques research and supply.
The company gives up copying overseas expired patented pharmaceuticals, a fast growing but lack of long-term driving force way which most domestic pharmaceutical companies take nowadays, while we don’t set an impractical goal about developing new drugs in the very beginning. Instead, with foothold in enterprise reality and personnel strengths as well as cooperating with domestic and foreign chemical/pharmaceutical corporations, the company walks out a unique win-win road: developing new synthesis process mainly, innovating drug development secondarily, aiming at bringing domestic pharmaceutical enterprises to overcome the technical barriers, while achieving our self-value. Our goal is: To provide highly efficient and quality R&D services to our customers, to help them complete production process smoothly, and satisfy them with every other needs.
Currently our company mainly emphasizes on the research about new synthesis processes of the depressor for ACE. Compared to normal methods, the new techniques introduce a totally new pathway. The cost is greatly reduced and the quality of the products is significantly enhanced, former side products in the final stage of normal synthesis process now represent a much lower content, the reaction condition is mild, suitable for industrialization production, all these suggesting a very promising market prospect. Presently, the laboratory R&D project has already been finished, and the next stage is testing in workshop. We have also conducted a primary laboratory test on a category three anti-allergy drug, now it is in the process of clinical stage declaring.
We have a powerful R&D team. The director of technology, got his Ph.D. from Peking University and continued pursuing his study overseas. He did his post-doctoral research in Hong Kong Technology University and Sweden Gotenburg University, and has excellent academic achievements in many research areas, such as sugar and heterocyclic chemistry research. In recent years, he engages in introducing his research products to the market, and has achieved good results. The academic leader of the company is graduated from Chinese Academy of Sciences Institute of Shanghai Medicine, with the main research direction for the physiological activity of the extracts triptolide total synthesis work. The company’s main project principals are college-level or higher qualifications, above the middle title, with rich experience in large foreign companies for years and product development. Meanwhile, the company also has a team of foreign experts, university professors, and a consultant team to give advice on topics of the project and to provide technical support.
Company assigned to the Suzhou High-Tech Park District foreign students venture garden which is set up by Suzhou municipal government. We have such as SHIMADZU high performance liquid chromatography, gas chromatography, Bruker 300MHz NMR, Agilent liquid chromatography-mass spectrometry instruments, IR, UV, polarimeter, melting point and refractive instruments. This large number of analytical facilities provides us convenient tools to the project of company.